FactorX,
This is another inherent problem with this management - too many chiefs and not enough indians.
Always employing too many managers, general managers and so forth who have no idea how to 'work' and all they do is direct - I think.
We need some rubber on the floor so that plans can be achieved and not just 'wished for'.
They had similar issues with Gradipore AND Life Therapeutics, particularly towards the end of the road for LF.
What has happened with Dr James Atwood III who was a new Senior Appointment with immediate effect as Vice-President Sales (Inqsep) according to the 'announcement' on 18/2/10? He was previously the Chief Executive Officer of BioInquire!
Probably disappeared into the ether like a lot of other announcements.
Regards................
revenue vs salaries, page-5
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.002(50.0%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $47.00K | 9.194M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1699939 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 5372603 | 4 |
View Market Depth
| Last trade - 13.59pm 14/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
